StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.41−0.29 (-3.77%)

Close on Nov 17, 2026Market cap $671.08MP/E –Yield –

Verastem price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Verastem's price to book ratio was 16.5× on Nov 11, 2026, against 15.8× a year earlier. Over the last 5 years it ranged from 1.1× to 22.1×, with a median of 4.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202616.5×+0.3
2025Oct 31, 202516.1×−2.7
2024Dec 31, 202418.8×+16.3
2023Dec 29, 20232.5×+1.1
2022Dec 30, 20221.3×−2.6
2021Dec 31, 20213.9×+1.1
2020Dec 31, 20202.8×−1.8
2019Dec 31, 20194.6×+2.3
2018Dec 31, 20182.3×−0.7
2017Dec 29, 20173.0×+2.5
2016Dec 30, 20160.5×−0.1
2015Dec 31, 20150.6×−2.1
2014Dec 31, 20142.7×+0.4
2013Dec 31, 20132.3×+0.3
2012Dec 31, 20122.0×–

More Verastem figures

See a number that looks wrong?